With the number of entries exceeding expectations, the award enters the voting stage to select the top initiatives

São Paulo, March 2020 – With a total of 1655 entries, the Euro Innovation in Health Award – the largest award focused on medical innovation with a strong social impact in Brazil – reaches its final stages. The medical community can now vote on the 105 projects chosen by an independent jury, opting for the most innovative creations that can be implemented and that present effective or potentially verifiable results.

After registering on the award website, each professional can vote on up to 11 different initiatives, which will proceed to the final phase. These winners return for a second vote by the doctors who will choose the top initiative, also by a majority vote.

“Engagement by the medical community across Brazil was great and the total enrollment exceeded our expectations. These are interesting projects that reinforce the potential of professionals in the country to seek innovations focused on the health and well-being of our society,” comments Roberta Junqueira, Commercial Director at Eurofarma.

The purpose of the award is to recognize and offer incentives to doctors who develop innovative products and solutions to improve quality of life. Prizes distributions will total € 1,000,000.00 (one million euros), with 10 prizes corresponding to an amount in Brazilian reais of € 50,000.00 (fifty thousand euros) and a single prize to the top winner corresponding to an amount in Brazilian reais of € 500,000.00 (five hundred thousand euros). The amounts of the awards will be converted into Brazilian reais and will be subject to income tax withholding (IRRF), according to current legislation.

To vote, simply access the site and register at www.premioeuro.com.br.

 

About the Award

The unprecedented award will distribute a total of 1 million euros (equivalent in Brazilian reais, subject to withholding of IRRF at the payment source), and is intended exclusively for doctors throughout Brazil who, using creativity, technical knowledge and sensitivity, create solutions for products and services with a high social and/or scientific impact. As official sponsor, Eurofarma embraced the award due to its strong social appeal, coupled with its belief in the appreciation of the Brazilian medical class.

 

About Eurofarma Group

Eurofarma is a health company focused on offering products and services to improve people’s lives with quality, innovation and fair prices across all major pharmaceutical segments: Prescription, Generic, Hospital, Oncology, and Nonprescription Drugs, as well as Veterinary Medicine. In Brazil alone, the company offers 287 different molecules and over 600 products. Eurofarma is a leader in medical prescriptions, serving 30 different specialties and covering 101 therapeutic classes, which account for 89% of retail pharmaceutical sales. The company has the largest sales force in the country, which visits approximately 600,000 doctors monthly.

Founded in 1972 and the first pharmaceutical multinational with 100% Brazilian capital, it has own operations in 20 countries and maintains a major manufacturing park in Brazil, as well as plants in 6 other Latin American countries. The group reported sales of BRL 4.3 billion in 2018 and employs over 6,700 employees.

 

Eurofarma in social media

Facebook: @eurofarma | LinkedIn: @eurofarma | Instagram:@eurofarma_br